WORKING GROUP NAME: PATIENT PREFERENCES TO VALUE HEALTH OUTCOMES IN RHEUMATOLOGY CLINICAL TRIALS (PPRCTs)

Researchers, patients, clinicians and policy-makers need to make certain trade-offs when making treatment decisions. These trade-offs include treatment safety, cost, duration, and effectiveness. Understanding patient preferences for these trade-offs is critical to making sure that the evidence we generate and use is relevant for the patients and physicians who have to make these choices every day. Our work will provide foundational knowledge regarding the most appropriate and feasible methods researchers can use to measure patient preferences to inform clinical trial design and interpretation